More specifically, the BRAF mutation is quite common in these cancers as well, accounting for 30% of ovarian tumors, 40% of papillary thyroid cancers, 50–70% of melanomas, and nearly 100% of hairy cell leukemias [55]. Here, BRAF is linked to melanoma.